VAPOR - Water Vapor for Prostate Cancer - Clinical Trial
What is the Purpose of this Study?
We are doing this study to find out if the Vanquish Water Ablation System (VAPOR), which uses small amounts of steam to destroy cancer cells, is a safe and effective method for treating intermediate-risk prostate cancer.
Prostate Cancer
Who Can Participate in the Study?
Adults ages 50+ who are diagnosed with intermediate-risk prostate cancer.
For more information, contact the study team at shawna.pochan@duke.edu.
What is Involved?
If you choose to join this study, you will go through a screening period to make sure you are eligible to take part. If you meet the study's criteria, you will have the procedure done under general anesthesia. A device is inserted into the urethra and advanced to the prostate. A small needle-shaped catheter is then deployed from the device and moved to the cancerous tissue. The physician then delivers steam for 10 seconds as a measure to destroy the cancer cells. We will keep in touch with you for five years following this procedure.
Study Details
